Lisinopril/hydrochlorothiazide combination therapy
Pro Research Analysisby 
Searched over 200M research papers
Efficacy of Lisinopril/Hydrochlorothiazide Combination Therapy for Hypertension
Multiple studies show that the combination of lisinopril and hydrochlorothiazide (HCTZ) is more effective at lowering blood pressure than either drug alone. In both short-term and long-term studies, patients receiving the combination experienced greater reductions in both systolic and diastolic blood pressure compared to those on monotherapy with either lisinopril or HCTZ 2346+3 MORE. The combination therapy also proved effective in elderly patients and those with mild, moderate, or severe hypertension, with a high percentage of patients reaching target blood pressure levels 7910.
Safety and Tolerability of Lisinopril/Hydrochlorothiazide
The combination of lisinopril and HCTZ is generally well tolerated. The most common side effects reported include dizziness, headache, cough, fatigue, orthostatic effects, diarrhea, and nausea, but these were infrequent and rarely led to withdrawal from treatment 147. The safety profile of the combination is similar to that of the individual components, and severe adverse events are uncommon 1467+1 MORE. In elderly and renally impaired patients, the adverse event profile remains consistent with the general population 19.
Metabolic Effects and Laboratory Findings
The combination therapy can cause increases in serum glucose, triglycerides, uric acid, serum creatinine, and blood urea, as well as decreases in serum potassium 1348+1 MORE. However, lisinopril can attenuate some of the negative metabolic effects of HCTZ, particularly the reduction in serum potassium, making the combination metabolically safer than HCTZ alone 1348+1 MORE. Both the combination and HCTZ alone can increase uric acid levels, but the risk of hypokalemia is lower with the combination 3489.
Comparison with Other Antihypertensive Combinations
When compared to captopril/HCTZ combinations, lisinopril/HCTZ provides similar or greater reductions in blood pressure, especially in diastolic values, and is equally well tolerated 58. The combination also shows superior efficacy at trough blood levels compared to captopril/HCTZ .
Patient Compliance and Long-Term Use
Studies indicate that patient compliance with lisinopril/HCTZ therapy is very good, with most patients maintaining adequate blood pressure control over long periods 610. The combination is effective and well tolerated in long-term use, with a low rate of adverse events and high rates of treatment continuation 610.
Conclusion
Lisinopril/hydrochlorothiazide combination therapy is a highly effective and well-tolerated option for managing mild to moderate hypertension. It offers superior blood pressure reduction compared to monotherapy, has a favorable safety profile, and is associated with good patient compliance and sustained long-term efficacy 1234+6 MORE.
Sources and full results
Most relevant research papers on this topic